About the Programme
Despite the rapid growth of the pharmaceutical industry and an increasing recognition of the importance of the medical affairs function within the region, there are few training programmes specifically designed to develop medical affairs professionals. Clinical expertise and medical knowledge are no longer the main requisites for this role.
Targeted training is necessary to help professionals tap into their medical and clinical expertise, while responding quickly and strategically to the ever-changing industry and regulatory trends. The growing emphasis on transparency in decision-making, increasing quantity and accessibility of health-related data, and the expanding role of patients in personal healthcare decision making – are a few examples of the key driving factors underlying the change.
Responsible for bridging pharmaceutical development to commercialisation, medical affairs personnel are expected to navigate through an increasingly complex healthcare environment with a need to have an optimal blend of scientific knowledge, communication skills, and business acumen to succeed in their role.
To address the competency and development needs arising from this evolving role of medical affairs within the pharmaceutical industry in response to the changing healthcare landscape, CoRE and Janssen Asia Pacific, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, have formed the Joint Alliance Duke-NUS Education (JADE), a certificate programme specialising in Medical Affairs.
JADE consists of 12 blended courses and provides a comprehensive curriculum representing the perspectives of stakeholders involved across the entire spectrum of activities in medical affairs – industry, researchers, academia, and public health experts. Topics of practical relevance will help learners to build a strong foundation in both the scientific knowledge and understanding of the various functions in medical affairs, enabling them to be effective contributors in this important field.